India to Algeria: Trastuzumab Export Trade Route

The India to Algeria Trastuzumab corridor is one of India's established pharmaceutical export routes, with 8 shipments documented worth a combined $1.9M USD. The route is dominated by MYLAN LABORATORIES LIMITED , which alone accounts for roughly 85% of all export value, reflecting the consolidated nature of India's trastuzumab manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $242.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with trastuzumab's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 25.7%, placing it at rank #6 among India's top trastuzumab export destinations globally.

On the import side, key buyers of Indian trastuzumab in Algeria include PHARMACIE CENTRAL DES HOPITAUX , HOPITAL CENTRAL DE IARMEE , HOPITAL CENTRAL DE L ARMEE and 3 others. PHARMACIE CENTRAL DES HOPITAUX is the single largest importer with 1 shipments valued at $1.7M USD.

India's trastuzumab exports to Algeria are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Algeria benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED , DR.REDDY'S LABORATORIES LTD , DR.REDDY'S LABORATORIES LTD — together account for 100% of total trade value on this route. The average shipment value of $242.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as trastuzumab sol inj 150mg ampoule(hervyc and trastuzumab sol inj 150 mg(hervycta 150mg)(trastuzumab 150 mg)(qty:250 vials), suggesting that buyers in Algeria tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, PHARMACIE CENTRAL DES HOPITAUX is the largest importer with 1 shipments worth $1.7M USD — representing 85% of all trastuzumab imports from India on this route. A total of 6 buyers are active on this corridor.